A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

NCT01511432 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: telaprevir formulation A
DRUG: telaprevir Formulation B
DRUG: telaprevir Formulation C
DRUG: telaprevir Formulation D

Sponsor

Vertex Pharmaceuticals Incorporated